Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy
2024 · Molecular Therapy · 17 citations
https://doi.org/10.1016/j.ymthe.2024.06.006
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Adil Ali Sayyed is an academic researcher.
Click to start Chat